CEBPZ and acute myeloid leukemia: Specifically, favorable rearrangements such as t(15;17) or core binding factor (CBF) translocations induced by topoisomerase-II inhibitors exposures retain their favorable prognosis also for sAML, although to a lesser extent for CBF AML [32,33,34,35].